$SNEX

FOWLER JOHN MOORE sold $119K of SNEX

FOWLER JOHN MOORE sold 1,575 shares of StoneX Group Inc. (SNEX) at $75.41 ($0.12M total) on 2026-08-05 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · FOWLER JOHN MOORE
Published Aug 6, 2026, 8:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 9:41 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SNEX
Neutral
high confidence
Mentioned
$SNEX
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SNEXNeutralLow
01

Why it matters

The newest fact is the director’s Aug. 5 open-market sale details (shares, price, total value) and that it was executed under a pre-arranged 10b5-1 plan.

02

Market read

Routine 10b5-1 insider selling is typically low-signal; any trading impact is likely limited to short-term sentiment.

03

What to watch

The filing does not disclose any new company performance, guidance, or risk event; traders should avoid over-weighting the sale size versus the director’s remaining holdings.

Relevance 3/10Novelty 3/10Timing: filed Aug. 6 after the Aug. 5 sale

Background

The article is an SEC Form 4 insider transaction disclosure for StoneX Group Inc. (SNEX).

Company-level read

Ticker impact

$SNEXNeutralHigh confidence
Context

StoneX Group Inc. disclosed a director open-market sale of 1,575 shares at $75.41 on a 10b5-1 plan, filed Aug. 6.

Expected impact

Low likelihood of a sustained price move; any reaction is likely short-lived and sentiment-driven.

Evidence & confidence

Form 4 shows a planned open-market transaction by a director, with no accompanying operational, financial, or regulatory catalyst in the filing text.

Market effects

Minimal, as the disclosure is company-specific and does not indicate sector-wide changes.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a 10b5-1 plan, it may reflect liquidity planning rather than bearish expectations.

Key entities

  • StoneX Group Inc.

    Company subject of the Form 4 insider transaction disclosure.

  • Fowler John Moore

    Director who sold 1,575 shares in an open-market transaction under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$WGOMedAI 8/10

Winnebago stock rises as StoneX lowers price target on industry outlook

StoneX lowered its price target on Winnebago (WGO) to $36 from $40, maintaining a Buy rating. The stock trades at $26.83 with a 5.62% dividend yield. Winnebago issued fiscal 2027 guidance for sales of $2.65B-$2.80B and adjusted EPS of $1.65-$2.25, with midpoints above consensus. The company reduced 2026 RV shipment expectations and guided 2027 shipments to 265,000-295,000 units. The stock rose 10.5% on Monday following earnings and guidance.

$MXLMed

MaxLinear stock rating reiterated at Buy by StoneX ahead of results

StoneX reiterated a Buy rating on MaxLinear (MXL) with a $125 price target ahead of its October 22 earnings report. The firm expects Q3 revenue of $215M-$220M, matching consensus. MXL shares are down 20% in a week but up 320% year-to-date. S&P upgraded its outlook to positive, citing strong infrastructure revenue growth. Analysts highlight MXL's potential in the optical market.

$EQBKMed

StoneX lowers Equity Bancshares stock price target on NIM outlook

StoneX reduced its price target for Equity Bancshares (EQBK) to $58 from $59, citing net interest margin expectations. The firm raised its fiscal 2026 EPS forecast to $5.18 but lowered the 2027 estimate to $5.27. EQBK's stock trades at a P/E ratio of 10.58, and analysts expect net income growth. The company recently reported Q3 earnings beating estimates, with EPS of $1.40 vs. $1.29 expected, but revenue missed slightly.